NVSEF - Merck touts new Keytruda version as patent cliff approaches
2024-03-08 14:02:46 ET
More on Merck
- Merck & Co., Inc. (MRK) TD Cowen 44th Annual Healthcare Conference (Transcript)
- Merck: A Great Dividend Growth Stock, But Not At This Price
- Merck: A High-Conviction Investment For Long-Term Growth
- Gilead, Merck once weekly combo HIV therapy shows promise in phase 2
- Biden to launch task force to target health care costs - report